肺动脉高压患者 COVID-19 相关死亡率的趋势：COMPERA 分析,European Respiratory Journal

当前位置： X-MOL 学术 › Eur. Respir. J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

肺动脉高压患者 COVID-19 相关死亡率的趋势：COMPERA 分析
European Respiratory Journal ( IF 16.6 ) Pub Date : 2023-04-27 , DOI: 10.1183/13993003.02440-2022
Kai-Helge Schmidt ₁ , Katrin Milger ₂ , Christine Pausch ₃ , Doerte Huscher ₄ , David Pittrow _{3,

5} , Ekkehard Grünig ₆ , Gerd Staehler ₇ , Henning Gall _{8,

9} , Oliver Distler ₁₀ , Dirk Skowasch ₁₁ , Michael Halank ₁₂ , Heinrike Wilkens ₁₃ , Matthias Held ₁₄ , Hans Klose ₁₅ , Marius M Hoeper _{16,

17}

Affiliation

Department of Cardiology and Center of Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.
Department of Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M), member of the German Center for Lung Research (DZL), Munich, Germany.
GWT-TUD GmbH, Innovation Center Real-World Evidence, Dresden, Germany.
Institute of Biometry and Clinical Epidemiology, and Berlin Institute of Health, Charité-Universitätsmedizin, Berlin, Germany.
Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany.
Center for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital, Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
Fachklinik Löwenstein, Löwenstein, Germany.
Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.
German Center of Lung Research (DZL), Germany.
Department of Rheumatology, University Hospital, Zurich, Switzerland.
Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik II, Innere Medizin - Kardiologie/Pneumologie, Bonn, Germany.
Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany.
Klinik für Innere Medizin V, Pneumologie, Universitätsklinikum des Saarlandes, Homburg, Germany.
Department of Internal Medicine, Respiratory Medicine and Ventilatory Support, Medical Mission Hospital, Central Clinic Würzburg, Würzburg, Germany.
Department of Respiratory Medicine, Eppendorf University Hospital, Hamburg, Germany.
German Center of Lung Research (DZL), Germany
Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.

肺动脉高压 (PH) 患者是受严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 引起的 2019 冠状病毒病 (COVID-19) 大流行严重影响的人群之一。早期病例系列报道了 11-70 名 PH 患者感染 COVID-19 的小系列病例死亡率为 19-45% [1-4]。在 2020 年 2 月至 2021 年 4 月期间发展为 COVID-19 的 211 名患有各种形式 PH 的法国患者的前瞻性研究发现，总体病死率为 24.6% [5]。

"点击查看英文标题和摘要"

更新日期：2023-04-27

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11